Additionally, the potential for side effects, interactions with other medications, and the individuals response to treatment should all be considered
Join now Sign in Conditions Search conditions Treatments Symptoms About PatientsLikeMe Crisis Back to top User Done
Second, injectable methylcobalamin bypasses gastric absorption, which is exactly the pathway semaglutide slows
Numerous GLP-1 receptor-targeting drugs have been investigated in clinical studies for various indications, including type 2 diabetes and obesity (accounts for 70% of the total studies), non-alcoholic steatohepatitis, Alzheimer's disease, and Parkinson's disease
What we do have is preclinical and pharmacokinetic data that inform us of its similarity with FDA-approved GLP-1s